 |
Video: What is a Stock Split?
|
 |
Chromadex Corp. is a global bioscience company. Co. is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. Its segments include Consumer Products, Ingredients and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the Co.'s proprietary ingredients, commercialized as Tru Niagen, directly to consumers and distributors. According to our CDXC split history records, CDXC has had 1 split. | |
 |

CDXC (CDXC) has 1 split in our CDXC split history database. The split for CDXC took place on April 13, 2016. This was a 1 for 3 reverse split, meaning for each 3 shares of CDXC owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 333.333333333333 share position following the split.
When a company such as CDXC conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the CDXC split history from start to finish, an original position size of 1000 shares would have turned into 333.333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CDXC shares, starting with a $10,000 purchase of CDXC, presented on a split-history-adjusted basis factoring in the complete CDXC split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2015 |
|
End date: |
03/18/2025 |
|
Start price/share: |
$3.69 |
|
End price/share: |
$7.87 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
113.28% |
|
Average Annual Total Return: |
7.96% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$21,334.12 |
|
Years: |
9.89 |
|
|
 |
Date |
Ratio |
04/13/2016 | 1 for 3 |
|
 |